 chemoprotect effect recombin human alpha cyclophosphamide-tr normal tumor-bear mice protect acut toxic hematolog effect develop late mortal therapeut efficaci studi recombin human alpha alpha normal tumor-bear balb/c mice acut toxic lethal dose cyclophosphamid Cy pretreat mice day u/day alpha mice acut death lethal dose Cy mg/kg mg/kg contrast post-treat mice singl multipl dose alpha chemoprotect pretreat mice alpha acut Cy mg/kg mg/kg normal mice dose-modifi effect rapid recoveri neutropenia sever reduct number bone marrow singl lineag monocyt myeloid myelomonocyt coloni mice pretreat alpha day mice extens pulmonari inflamm fibrosi death mice murin renal cancer renca acut toxic effect Cy mg/kg pretreat alpha renca-bear mice alpha subleth mg/kg lethal mg/kg Cy surviv time untreat renca-bear mice caus death renca-bear mice treatment alpha mg/kg Cy recurr tumor mice alpha mg/kg Cy detect tumor sever late pulmonari inflamm fibrosi dose escal Cy alpha-pretr mice result antitumor effect Cy dose escal cytotox agent use myelostimulatori agent late fatal complic acut toxic test